Prostate Cancer Therapeutics

A Global Strategic Business Report

MCP-1747

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

8132

EXECUTIVE POOL

5850

PRICE

1138

EXPERT INPUTS

76

COMPANIES

111

DATA TABLES

217

PAGES

15

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (30843)

946

CXO

1868

VICE PRESIDENT

14807

DIRECTOR

9517

MANAGER

3705

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Prostate Cancer Therapeutics Market to Reach US$26.4 Billion by 2030

The global market for Prostate Cancer Therapeutics estimated at US$18.0 Billion in the year 2024, is expected to reach US$26.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by the end of the analysis period. Growth in the Targeted Therapy segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.0% CAGR

The Prostate Cancer Therapeutics market in the U.S. is estimated at US$5.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Prostate Cancer Therapeutics Market - Key Trends and Drivers Summarized

What Are the Current Therapeutic Approaches for Prostate Cancer?

Prostate cancer therapeutics encompass a wide range of treatments designed to manage and treat prostate cancer, which is one of the most common cancers among men worldwide. The primary therapeutic approaches include surgery, radiation therapy, hormone therapy, chemotherapy, and more recently, immunotherapy and targeted therapies. Surgical options, such as radical prostatectomy, involve the removal of the prostate gland and are typically recommended for localized cancers. Radiation therapy, delivered either externally or through brachytherapy, targets cancer cells with high-energy rays. Hormone therapy, or androgen deprivation therapy (ADT), reduces the levels of male hormones that fuel prostate cancer growth. Chemotherapy, although less commonly used in early stages, is employed for advanced or hormone-refractory prostate cancers. These treatments are often used in combination to maximize effectiveness and manage the disease more comprehensively.

How Are Emerging Therapies Changing the Landscape of Prostate Cancer Treatment?

Emerging therapies are revolutionizing the treatment landscape for prostate cancer by offering more targeted and personalized treatment options. One of the most promising areas is the development of novel androgen receptor inhibitors, such as enzalutamide and apalutamide, which are more effective in blocking the signals that promote cancer growth. Immunotherapy, particularly the use of immune checkpoint inhibitors, is also gaining traction, although its success in prostate cancer has been more limited compared to other cancers. Another significant advancement is the use of radioligand therapy, such as lutetium-177-PSMA-617, which delivers targeted radiation to prostate-specific membrane antigen (PSMA)-expressing cells. Additionally, PARP inhibitors, like olaparib, have shown efficacy in patients with specific genetic mutations, providing a new avenue for personalized treatment. These innovative therapies are not only improving survival rates but also enhanciwng the quality of life for patients by reducing the side effects associated with traditional treatments.

What Innovations Are Driving the Future of Prostate Cancer Therapeutics?

The future of prostate cancer therapeutics is being shaped by several key innovations and research advancements. Precision medicine, which involves tailoring treatment based on the genetic profile of the individual and their tumor, is becoming increasingly important. Advances in genetic and molecular profiling are enabling the identification of specific biomarkers that can predict response to certain therapies, leading to more effective and individualized treatment plans. Additionally, the integration of artificial intelligence and machine learning in clinical practice is enhancing the ability to analyze vast amounts of data and improve decision-making processes. Another significant trend is the development of minimally invasive treatments, such as high-intensity focused ultrasound (HIFU) and cryotherapy, which offer effective cancer control with fewer side effects. These innovations are not only enhancing therapeutic outcomes but also paving the way for new treatment paradigms that prioritize patient-specific approaches and long-term disease management.

What Factors Are Driving the Growth in the Prostate Cancer Therapeutics Market?

The growth in the prostate cancer therapeutics market is driven by several factors. The increasing incidence of prostate cancer, particularly among aging populations, is a major driver, necessitating the development of effective treatments. Technological advancements in diagnostic and treatment modalities are also propelling market growth, as they enable earlier detection and more precise treatment options. The rise of personalized medicine and the identification of specific genetic and molecular targets are expanding the therapeutic arsenal and improving treatment outcomes. Additionally, increased funding for cancer research and development from both public and private sectors is accelerating the introduction of innovative therapies. The growing awareness and screening initiatives for prostate cancer are leading to higher diagnosis rates and subsequent treatment demand. These factors collectively underscore the dynamic and expanding landscape of the prostate cancer therapeutics market, highlighting its critical role in improving patient outcomes and advancing cancer care.

SCOPE OF STUDY

The report analyzes the Prostate Cancer Therapeutics market by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Hormone Therapy, Targeted Therapy, Chemotherapy, Targeted Therapy); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online sales, Other Distribution Channels).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

AbbVie Inc.; Allergan plc; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca Plc.; Bayer AG; Bristol-Myers Squibb Company; Debiopharm Group; Endo Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biotech Inc.; Novartis AG; Pfizer Inc.; Progenics Pharmaceuticals Inc.; Sanofi S.A.; Spectrum Pharmaceuticals Inc.; Takeda Pharmaceutical Company Limited; TOLMAR Pharmaceuticals Inc.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Global Economic Update

Prostate Cancer Therapeutics – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 76 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Advances in Precision Medicine Propel Growth in Prostate Cancer Therapeutics

Increasing Prevalence of Prostate Cancer Spurs Demand for Advanced Treatments

Breakthroughs in Immunotherapy Strengthen Business Case for Prostate Cancer Therapeutics

Growing Awareness and Screening Programs Accelerate Demand for Early Treatment Options

Hormone Therapy Developments Expand Addressable Market Opportunity

Innovations in Radiopharmaceuticals Propel Growth in Prostate Cancer Management

Regulatory Approvals of Novel Drugs Drive Adoption of Advanced Prostate Cancer Treatments

Increasing Investment in Oncology Research Strengthens Prostate Cancer Therapeutics Market

Biopharmaceutical Collaborations and Partnerships Spur Innovation in Prostate Cancer Treatments

Aging Population Sustains Growth in Prostate Cancer Therapeutics Market

Expanding Use of Combination Therapies Generates Opportunities in Prostate Cancer Treatment

Growing Pipeline of Prostate Cancer Drugs Strengthens Market Competitiveness

4. GLOBAL MARKET PERSPECTIVE

World Prostate Cancer Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hormone Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Online Sales by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

JAPAN

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

CHINA

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

EUROPE

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

FRANCE

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

GERMANY

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

UNITED KINGDOM

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2015, 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
AB Science SA	%
Active Biotech AB	%
Adelaide Health Care	%
Arkansas Urology Limited	%
Astellas Pharma, Inc.	%
AstraZeneca Plc	%
Aytu BioScience, Inc.	%
Bellicum Pharmaceuticals, Inc.	%
Bristol-Myers Squibb Company	%
Cancer Research Technology Ltd.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll